Biotech SF
San Francisco Bay Area biotech stories.
Thursday, August 9, 2012
Growing Nodality strikes drug-development deal with Pfizer
Nodality Inc. scored a deal Thursday to help
Pfizer Inc.
, the world's largest drug maker, better develop drugs
. The multi-year deal, financial terms for which weren't disclosed, initially will focus on autoimmune diseases, particularly lupus. Plus, Pfizer has an option to use Nodality's technology to develop companion diagnostics.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment